Summary of ASH 2024: Key Insights and Highlights

Published on December 13, 2024

ASH 2024 brought together global experts to discuss the latest developments in the treatment and management of myeloproliferative neoplasms (MPNs). Peter Loffelhardt, the Founder and President of the Global MPN Scientific Foundation, attended this important event, where discussions focused on new therapeutic options, advancements in clinical trials, and the evolving landscape of MPN care. The symposium provided valuable insights for both healthcare professionals and patients, particularly around personalized treatments and patient-centered care.

https://vimeo.com/1038856851/27a6f38f66?share=copy 

 

Other news

Webinar: What is a Combo Treatment in MPN?

December 12, 2024
Our last webinar of the year is a special opportunity to learn about combo treatments in the context of MPNs. On Monday, December 23rd, 2024, from 5 PM to 7 PM (CET), Global MPN Scientific Foundation is hosting a roundtable discussion to explore a new potential treatment and the role of combination therapies in MPN management. We are thrilled to be joined by Karyopharm, a pharmaceutical company wi

Summary and Videos of the Webinar: "Commemorating Myelofibrosis Awareness Day"

December 18, 2024
In honor of Myelofibrosis Awareness Day on November 26th, Global MPN Scientific Foundation hosted a special roundtable discussion on December 3rd, 2024, from 6 PM to 8 PM (CET). This event was exclusively designed for myelofibrosis patients and caregivers, offering a safe space for sharing experiences, challenges, and stories of hope. The roundtable provided a platform for participants to connect